McKesson Corp appoints Mark Walchirk as President
McKesson Corporation announced that Mark Walchirk has been appointed President, McKesson U.S. Pharmaceutical with immediate effect. Walchirk who was recently Chief Operating Officer of McKesson Specialty Health, has held many leadership roles at McKesson for last 11 years.
Mark will succeed Brian Tyler who was recently appointed Executive Vice President of corporate strategy and business development, McKesson Corporation.
Walchirk will be reporting to the Executive Vice President and Group President of McKesson Corporation, Mr. Paul Julian.
Mark will be responsible to oversee McKesson’s Paul Julian, Executive Vice President and Group President, McKesson Corporation said, “With past roles as Chief Operating Officer of McKesson U.S. Pharmaceutical and McKesson Specialty Health, Mark Walchirk has deep leadership experience in our pharmaceutical distribution business and a proven track record of delivering results for our customers.”
Mr. Paul also said, “Mark’s significant experience coupled with his commitment to operational experience and our customers’ success make him the ideal choice to lead McKesson U.S. Pharmaceutical.”
Mark will oversee McKesson’s largest business, which supplies branded, generic and over-the-counter pharmaceuticals and value-added business, clinical and connectivity solutions to over 40,000 customers including hospitals, retain chains, independent retail pharmacies, integrated delivery networks and long-term care providers.
Walchirk spent 13 years in medical-surgical distribution and manufacturing with Baxter Healthcare, Allegiance Healthcare and Encompass Group, holding leadership positions in sales, marketing, operations and development.
Mr. Walchirk has completed his BS in business administration from the University of Illinois in 1988. Currently, he serves on the board of the Center for Healthcare Supply Chain Research and GS1 Healthcare U.S.
